Clinical Trial Update: A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. [Phase 2]

View source ↗

Summary

Phase 2 trial by GlaxoSmithKline evaluated antibody persistence and booster response, as well as safety, in individuals previously primed with Hib, tetanus, per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• GSK Hib/Tdap/HepB booster vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Tetanus | Phase 2 | Status: COMPLETED